1423
We describe a case of a man treated with an EGFR-inhibitor (erlotinib) for a cell lung cancer who developed skin manifestations localized in an uncommon area and with an atypical evolution.
 a man: Subject; man: Subject.Gender; skin manifestations localized in an uncommon area and with an atypical evolution: Effect; EGFR-inhibitor (erlotinib): Treatment; cell lung cancer: Treatment.Disorder; EGFR-inhibitor: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a man: Subject; man: Subject.Gender; skin manifestations localized in an uncommon area and with an atypical evolution: Effect; EGFR-inhibitor (erlotinib): Treatment; cell lung cancer: Treatment.Disorder; EGFR-inhibitor: Treatment.Drug